James W. Stave
Corporate Officer/Principal at CD Diagnostics, Inc.
Profile
James W.
Stave is currently the Vice President-Research & Development at CD Diagnostics, Inc. He was previously the Chief Science Officer & VP-Research & Development at Standard Diversified, Inc. from 1991 to 2011.
He received his undergraduate degree from Michigan Technological University and his doctorate from the University of Maryland.
James W. Stave active positions
Companies | Position | Start |
---|---|---|
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | Corporate Officer/Principal | 07/05/2014 |
Former positions of James W. Stave
Companies | Position | End |
---|---|---|
STANDARD DIVERSIFIED INC | Chief Tech/Sci/R&D Officer | 30/11/2011 |
Training of James W. Stave
University of Maryland | Doctorate Degree |
Michigan Technological University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Standard Diversified, Inc.
Standard Diversified, Inc. TobaccoConsumer Non-Durables Standard Diversified, Inc. is a holding company, which owns and operates subsidiaries in a variety of industries, including other tobacco products, insurance, and outdoor advertising. It operates through the following segments: Smokeless Products, Smoking Products, and NewGen Products. The Smokeless Product segment manufactures and markets moist snuff and contracts for and markets chewing tobacco products. The Smoking Products segment imports and markets cigarette papers, tubes, and related products; imports and markets finished cigars, MYO cigar tobaccos, and cigar wraps; and processes, packages, and markets pipe tobaccos. The NewGen Products segment trades e-cigarettes, e-liquids, vaporizers, and other related products; and distributes a wide assortment of vaping products to non-traditional retail outlets via VaporBeast and Vapor Shark. The company was founded by Martha C. Reider, Anne Cavanaugh and Richard C. Birkmeyer in 1990 and is headquartered in New York, NY. | Consumer Non-Durables |
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | Health Technology |
- Stock Market
- Insiders
- James W. Stave